Circulating antibody-secreting cell response during Mycoplasma pneumoniae childhood pneumonia.

P. M. Meyer Sauteur,J. Trück,C. Berger,A. V. van Rossum
DOI: https://doi.org/10.1093/infdis/jiaa062
2020-02-08
Abstract:BACKGROUND We recently demonstrated that the measurement of Mycoplasma pneumoniae (Mp)-specific IgM antibody-secreting cells (ASCs) improved diagnosis of Mp infection. Here, we aimed to describe Mp ASC kinetics and duration in comparison to conventional measures such as pharyngeal Mp DNA and serum antibodies. METHODS Prospective longitudinal study of 63 community-acquired pneumonia (CAP) patients and 21 healthy controls (HCs), 3-18 years of age, from 2016-2017. Mp ASCs measured by enzyme-linked immunospot (ELISpot) were assessed alongside Mp DNA and antibodies during 6-month follow-up. RESULTS Mp ASCs of the isotype IgM were found in 29 (46%), IgG in 27 (43%), and IgA in 27 (43%) CAP patients. Mp ASCs were detected from 2 days to maximum 6 weeks after symptom onset, while Mp DNA and antibodies persisted until 4 months (p=0.03) and 6 months (p<0.01). Mp ASCs were undetectable in HCs, in contrast to detection of Mp DNA in 10 (48%) or antibodies in 6 (29%) controls for prolonged time. The Mp ASC response correlated with clinical disease, but did not differ between patients treated with or without antibiotics against Mp. CONCLUSIONS Mp-specific ASCs are short-lived and associated with clinical disease, making it an optimal resource for determining Mp pneumonia etiology.
Medicine
What problem does this paper attempt to address?